News for Assertio Holdings, Inc. (ASRT)

LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (”œAssertio” or the ”œCompany”) ( ASRT) today announced that Brendan O'Grady

Assertio Holdings (ASRT) is set to participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025. CEO Brendan O'Grady will lea

**media[630788]**

On May 19, 2025, analyst Raghuram Selvaraju from HC Wainwright & Co. reiterated a Buy rating for Assertio Holdings (ASRT). The rating remains consistent with th

Net Product Sales: $26 million in Q1 2025, compared to $31.9 million in Q1 2024.Rovedon Sales: $13.1 million, down from $14.5 million in the prior year quarter

May 12, 2025 / 08:30PM GMTOperator Please stand by. Well, good day, ladies and gentlemen. Welcome to the Social Holdings first quarter 2025 results conference c

Summary: Assertio Holdings reports a decrease in net product sales for Q1 2025 but outlines strategic plans for growth.Analysts provide a promising upside poten

Submitted NDA for Anaphylmâ„¢ (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness

First Quarter Total Net Product Sales of $26.0 Million, In Line with 2025 Outlook Provides Update on Long-Term Business Strategy Designed to Create Susta

Revenue: Reported at $26.0 million, slightly below the estimated $27.52 million.Net Loss: Increased to $13.5 million from $4.5 million in the prior year quarte

LAKE FOREST, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (”œAssertio” or the ”œCompany”) ( ASRT) today announced that Brendan O'Gra

Release Date: March 12, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Assertio Holdin

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NASRT.OQ - Assertio Holdings IncQ4 2024 Assertio Holdings Inc Earnings CallMar 12, 2025 / 08:30

Assertio Holdings, Inc. (NASDAQ:ASRT) Q4 2024 Earnings Conference Call March 12, 2025 4:30 PM ETCompany ParticipantsMatthew Kreps - IRBrendan O'Grady -...

Fourth Quarter Net Product Sales $29.6 Million, Cash Flow from Operations of $11.5 Million Full Year Net Product Sales $120.8 Million, Rolvedon Sales Excee

CHICAGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed in Lake County Circuit Court, Nineteenth Judicial Circuit, State of Illinois,

LAKE FOREST, Ill., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (”œAssertio” or the ”œCompany”) (NASDAQ: ASRT), a pharmaceutical company wi

**media[505232]**

**media[494594]**